Design Therapeutics (DSGN) EPS (Basic) (2020 - 2026)
Design Therapeutics (DSGN) posted quarterly EPS (Basic) of -$0.37 for Q2 2026, up 2.52% year-over-year from -$0.36 in Q2 2025, and down 9.49% on a QoQ basis from -$0.34 in Q1 2026.
Design Therapeutics (DSGN) EPS (Basic) (2020 - 2026) Analysis & Trends
Design Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.37 in Q2 2026.
- EPS (Basic) for Q2 2026 came in at -$0.37, up 2.52% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.31 (down 1.03% YoY), and the FY2025 annual result was -$938.29, down 169.54% from the prior year.
- EPS (Basic) slipped to -$0.37 in Q2 2026, from -$0.34 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.24 in Q1 2024 and troughed at -$189.42 in Q4 2022.
- A 5-year average of -$10.88 and a median of -$0.37 in 2026 frame the typical range for EPS (Basic).
- The widest annual swing landed in 2022, when EPS (Basic) tumbled 76449.86%; it then soared 99.54% in 2023.
- A 5-year view of EPS (Basic) shows it stood at -$189.42 in 2022, then soared by 99.54% to -$0.86 in 2023, then surged by 66.64% to -$0.29 in 2024, then dropped by 10.19% to -$0.32 in 2025, then decreased by 17.96% to -$0.37 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.37 in Q2 2026, -$0.34 in Q1 2026, and -$0.32 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Design Therapeutics | 928.06 Mn | 720.67 Mn | - | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.37 |
| Mar 31, 2026 | -0.34 |
| Dec 31, 2025 | -0.32 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.38 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.29 |
| Sep 30, 2024 | -0.27 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.86 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -0.44 |
| Mar 31, 2023 | -0.44 |
| Dec 31, 2022 | -0.37 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | -0.39 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.25 |
| Sep 30, 2021 | -0.29 |